NUCLEOLIN and cancer: To address the hypothesis that NCL protects cancer cell-derived EV-associated miRNAs, we evaluated the ability of anti-NCL 4LB5-HP-RNase and 4LB5 scFv to modify the levels of EV-related miR-21 after the binding and the possible displacement of microRNAs from NCL.